Hospital Clinico Universitario de Valencia

Valencia, Other 46010

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small- Cell Lung, HER2 Positive Breast Cancer, Melanoma, Metastatic Colorectal Adenocarcinoma

Studies at this site

• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling
• A Study of SEA-CD40 Given With Other Drugs in Cancers — Completed
• Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer — Completed